Human immunodeficiency virus-associated squamous cell cancer of the anus: Epidemiology and outcomes in the highly active antiretroviral therapy era

Journal of Clinical Oncology

Volumn 26, Issue 3, 2008, Pages 474-479

  Chiao, Elizabeth Y ^a   Giordano, Thomas P ^a   Richardson, Peter ^a   El Serag, Hashem B ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AFRICAN AMERICAN; AGED; ANUS CARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; DATA BASE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 38649141144     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.2810     Document Type: Article

References (29)

1. Johnson LG, Madeleine MM, Newcomer LM, et al: Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience, 1973-2000. Cancer 101:281-288, 2004
2. Melbye M, Rabkin C, Frisch M, et al: Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol 139:772-780, 1994
3. Daling JR, Weiss NS, Klopfenstein LL, et al: Correlates of homosexual behavior and the incidence of anal cancer. JAMA 247:1988-1990, 1982
4. Daling JR, Weiss NS, Hislop TG, et al: Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 317:973-977, 1987
5. Melbye M, Sprogel P: Aetiological parallel between anal cancer and cervical cancer. Lancet 338:657-659, 1991
6. Palefsky JM, Holly EA, Ralston ML, et al: High incidence of anal high-grade squamous intraepithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 12:495-503, 1998
7. Piketty C, Darragh TM, Heard I, et al: High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 31:96-99, 2004
8. Wilkin TJ, Palmer S, Brudney KF, et al: Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis 190:1685-1691, 2004
9. Clifford GM, Polesel J, Rickenbach M, et al: Cancer risk in the Swiss HIV Cohort Study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97:425-432, 2005
10. Bower M, Powles T, Newsom-Davis T, et al: HIV-associated anal cancer: Has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr 37:1563-1565, 2004
11. Grulich AE, Wan X, Law MG, et al: Risk of cancer in people with AIDS. AIDS 13:839-843, 1999
12. Grulich AE, Li Y, McDonald A, et al: Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 16:1155-1161, 2002
13. Cleator S, Fife K, Nelson M, et al: Treatment of HIV-associated invasive anal cancer with combined chemoradiation. Eur J Cancer 36:754-758, 2000
14. Flam M, John M, Pajak TF, et al: Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 14:2527-2539, 1996
15. Chadha M, Rosenblatt EA, Malamud S, et al: Squamous-cell carcinoma of the anus in HIV-positive patients. Dis Colon Rectum 37:861-865, 1994
16. Vatra B, Sobhani I, Aparicio T, et al: Anal canal squamous-cell carcinomas in HIV positive patients: Clinical features, treatments and prognosis. Gastroenterol Clin Biol 26:150-156, 2002
17. Kim JH, Sarani B, Orkin BA, et al: HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients. Dis Colon Rectum 44:1496-1502, 2001
18. Efron JE, Pikarsky AJ, Gervaz P, et al: The efficacy of chemoradiation therapy in HIV seropositive patients with squamous cell carcinoma of the anus. Colorectal Dis 3:402-405, 2001
19. Palella FJ Jr, Delaney KM, Moorman AC, et al: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV Outpatient Study Investigators. N Engl J Med 338:853-860, 1998
20. Bower M, Gazzard B, Mandalia S, et al: A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy. Ann Intern Med 143: 265-273, 2005
21. Holland JM, Swift PS: Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy. Radiology 193:251-254, 1994
22. Oehler-Janne C, Seifert B, Lutolf UM, et al: Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy. Radiat Oncol 1:29, 2006
23. Place RJ, Gregorcyk SG, Huber PJ, et al: Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum 44:506-512, 2001
24. Page WF, Mahan CM, Kang HK: Vital status ascertainment through the files of the Department of Veterans Affairs and the Social Security Administration. Ann Epidemiol 6:102-109, 1996
25. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619, 1992
26. Edelman S, Johnstone PA: Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: Outcomes and toxicities. Int J Radiat Oncol Biol Phys 66:206-211, 2006
27. Stadler RF, Gregorcyk SG, Euhus DM, et al: Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy. Dis Colon Rectum 47:1305-1309, 2004
28. Blazy A, Hennequin C, Gornet JM, et al: Anal carcinomas in HIV-positive patients: High-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy. Dis Colon Rectum 48:1176-1181, 2005
29. Kramer JR, Giordano TP, Souchek J, et al: The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol 100:56-63, 2005